Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sci-B-Vac lot consistency in adults
NCT03408730Phase 3Completed
- Sponsor
- VBI Vaccines Inc.
- Start
- Dec 2017
- Primary completion
- Oct 2019
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 6
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by VBI Vaccines Inc.. Started Dec 2017; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03408730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408730.